Department of Cell and Molecular Pharmacology and Experimental Therapeutics,
Hollings Cancer Center
Russell Spencer-Smith has not added Biography.
If you are Russell Spencer-Smith and would like to personalize this page please email our Author Liaison for assistance.
Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene Apr, 2019 | Pubmed ID: 30573767
Correction: Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene May, 2019 | Pubmed ID: 30710144
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Cell reports Feb, 2022 | Pubmed ID: 35139380
Medical University of South Carolina
National Cancer Institute-Frederick
Russell Spencer-Smith1,2,3
1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina,
2Hollings Cancer Center, Medical University of South Carolina,
3Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
Forschung
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
Lehre
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Autoren
Bibliothekare
Zugang
ÜBER JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten